Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-12-012015
Filing Date
2012-11-20
Accepted
2012-11-20 14:14:24
Documents
1
Period of Report
2012-10-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rdgdoc.html 4  
1 PRIMARY DOCUMENT rdgdoc.xml 4 6200
  Complete submission text file 0001437749-12-012015.txt   7828
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
SIC: 2834 Pharmaceutical Preparations

Mailing Address NO. 100 WANG QIAO ROAD PUDONG AREA SHANGHAI F4 201201
Business Address NO. 100 WANG QIAO ROAD PUDONG AREA SHANGHAI F4 201201 86-21-50498986
NAQU AREA PIONEER PHARMA CO., LTD. (Reporting) CIK: 0001561909 (see all company filings)

State of Incorp.: F4 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 121217511